PRPF38B
Pre-mRNA-splicing factor 38B
Also known as: FLJ10330, NET1, PR38B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VTL8
- Gene
- PRPF38B
- Ensembl
- ENSG00000134186
- Chromosome
- 1
- Canonical length
- 546 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be located in nucleus. Predicted to be part of precatalytic spliceosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
546 residues, UniProt reviewed canonical sequence.
>Q5VTL8|PRPF38B
1 MANNSPALTG NSQPQHQAAA AAAQQQQQCG GGGATKPAVS GKQGNVLPLW GNEKTMNLNP
61 MILTNILSSP YFKVQLYELK TYHEVVDEIY FKVTHVEPWE KGSRKTAGQT GMCGGVRGVG
121 TGGIVSTAFC LLYKLFTLKL TRKQVMGLIT HTDSPYIRAL GFMYIRYTQP PTDLWDWFES
181 FLDDEEDLDV KAGGGCVMTI GEMLRSFLTK LEWFSTLFPR IPVPVQKNID QQIKTRPRKI
241 KKDGKEGAEE IDRHVERRRS RSPRRSLSPR RSPRRSRSRS HHREGHGSSS FDRELEREKE
301 RQRLEREAKE REKERRRSRS IDRGLERRRS RSRERHRSRS RSRDRKGDRR DRDREREKEN
361 ERGRRRDRDY DKERGNEREK ERERSRERSK EQRSRGEVEE KKHKEDKDDR RHRDDKRDSK
421 KEKKHSRSRS RERKHRSRSR SRNAGKRSRS RSKEKSSKHK NESKEKSNKR SRSGSQGRTD
481 SVEKSKKREH SPSKEKSRKR SRSKERSHKR DHSDSKDQSD KHDRRRSQSI EQESQEKQHK
541 NKDETVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRPF38B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 60 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 60 nTPM
- cerebellum: 55 nTPM
- lymph node: 43 nTPM
- spleen: 42 nTPM
- thymus: 35 nTPM
- small intestine: 34 nTPM
Single-cell type
- basal keratinocytes: 211 nCPM
- neutrophils: 204 nCPM
- suprabasal keratinocytes: 198 nCPM
- t-cells: 196 nCPM
- nk-cells: 185 nCPM
- microglia: 167 nCPM
Immune cell
- NK-cell: 32 nTPM
- neutrophil: 30 nTPM
- plasmacytoid DC: 28 nTPM
- eosinophil: 27 nTPM
- MAIT T-cell: 25 nTPM
- T-reg: 25 nTPM
Brain region
- cerebellum: 49 nTPM
- medulla oblongata: 31 nTPM
- white matter: 31 nTPM
- hypothalamus: 31 nTPM
- pons: 29 nTPM
- thalamus: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.7
- gnomAD missense Z
- 1.92
- DepMap mean gene effect
- -1.77
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRPF38B as an antibody target. Whether an autoantibody or antibody against PRPF38B could matter depends on whether native PRPF38B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRPF38B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRPF38B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...